• Betel quids raise pharma concerns in Bangladesh
    Chewing betel quids could lead Bangladeshi people to need pharma intervention


Betel quids raise pharma concerns in Bangladesh

Feb 08 2011

Pharma firms operating in Bangladesh must contend with relatively high levels of poisons including arsenic and manganese in the groundwater supply, note researchers writing in BMC Public Health.

The team from Leicester's De Montfort University explain that excessive manganese exposure can cause negative health effects similar to those seen in Parkinson's Disease.

However, they have now looked into the possibility of exposure to the element through betel quid chewing, using inductively coupled plasma mass spectrometry to analyse urinary output.

A betel quid consists of chopped areca nut, calcium hydroxide, flavourings such as tobacco leaves and an outer layer of Piper betel leaves.

Some ten per cent of the world's population chew betel quids on a daily basis, the researchers add.

However, the negative impacts could leave those in Bangladesh requiring pharmaceutical assistance, as they exhibited a 210 per cent increase in manganese concentration in their urine.

BMC Public Health specialises in publishing research pertaining to the epidemiology of disease and its impact on populations in general.

Digital Edition

Chromatography Today - Buyers' Guide 2022

December 2021

In This Edition Modern & Practocal Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...

View all digital editions


Lab Asia 2023

Oct 10 2023 Hybrid event

MicroTAS 2023

Oct 15 2023 Katowice, Poland

ISPPP 2023

Nov 05 2023 Vienna, Austria

SETAC North America

Nov 12 2023 Louisville, KY, USA

Eastern Analytical Symposium

Nov 13 2023 Plainsboro, NJ, USA

View all events